메뉴 건너뛰기




Volumn 56, Issue 4, 2013, Pages 937-938

Metformin and mortality

(1)  Lund, S S a  

a NONE   (Denmark)

Author keywords

Metformin; Mortality; Randomised clinical trials; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; INSULIN; METFORMIN; PLACEBO; SULFONYLUREA;

EID: 84876470820     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2843-y     Document Type: Letter
Times cited : (4)

References (8)
  • 1
    • 84866138849 scopus 로고    scopus 로고
    • Cancer outcomes and all-cause mortality in adults allocated to metformin: Systematic review and collaborative meta-analysis of randomised clinical trials
    • 22875195 10.1007/s00125-012-2653-7 1:CAS:528:DC%2BC38XhtlWlsrjP Erratum 55:3399-3400
    • Stevens RJ, Ali R, Bankhead CR et al (2012) Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials. Diabetologia 55:2593-2603, Erratum 55:3399-3400
    • (2012) Diabetologia , vol.55 , pp. 2593-2603
    • Stevens, R.J.1    Ali, R.2    Bankhead, C.R.3
  • 2
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
    • UK Prospective Diabetes Study (UKPDS) Group 10.1016/S0140-6736(98)07037-8 Erratum 352:1558
    • UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, Erratum 352:1558
    • (1998) Lancet , vol.352 , pp. 854-865
  • 3
    • 0032512250 scopus 로고    scopus 로고
    • The UK Prospective Diabetes Study
    • 9863807 10.1016/S0140-6736(05)60422-9 1:STN:280:DyaK1M%2FnvFGisw%3D%3D
    • Evans M (1998) The UK Prospective Diabetes Study. Lancet 352:1932-1933
    • (1998) Lancet , vol.352 , pp. 1932-1933
    • Evans, M.1
  • 4
    • 0032876628 scopus 로고    scopus 로고
    • Metformin and risk of cardiovascular disease
    • 10516415 10.1159/000006910 1:STN:280:DyaK1MvkslGrtA%3D%3D
    • Turner RC, Holman RR (1999) Metformin and risk of cardiovascular disease. Cardiology 91:203-204
    • (1999) Cardiology , vol.91 , pp. 203-204
    • Turner, R.C.1    Holman, R.R.2
  • 5
    • 84868005485 scopus 로고    scopus 로고
    • AMP-Activated protein kinase: A target for drugs both ancient and modern
    • 23102217 10.1016/j.chembiol.2012.08.019 1:CAS:528:DC%2BC38XhsF2hsbfF
    • Hardie D, Ross F, Hawley S (2012) AMP-Activated protein kinase: a target for drugs both ancient and modern. Chem Biol 19:1222-1236
    • (2012) Chem Biol , vol.19 , pp. 1222-1236
    • Hardie, D.1    Ross, F.2    Hawley, S.3
  • 6
    • 84868109993 scopus 로고    scopus 로고
    • Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs
    • 1:CAS:528:DC%2BC38Xht1anu7zF
    • Corominas-Faja B, Quirantes-Pine R, Oliveras-Ferraros C et al (2012) Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs. Aging (Albany NY) 4:480-498
    • (2012) Aging (Albany NY) , vol.4 , pp. 480-498
    • Corominas-Faja, B.1    Quirantes-Pine, R.2    Oliveras-Ferraros, C.3
  • 7
    • 84859884412 scopus 로고    scopus 로고
    • Mitochondria and cardiovascular aging
    • 22499901 10.1161/CIRCRESAHA.111.246140 1:CAS:528:DC%2BC38XlsVaktLk%3D
    • Dai DF, Rabinovitch PS, Ungvari Z (2012) Mitochondria and cardiovascular aging. Circ Res 110:1109-1124
    • (2012) Circ Res , vol.110 , pp. 1109-1124
    • Dai, D.F.1    Rabinovitch, P.S.2    Ungvari, Z.3
  • 8
    • 63849328978 scopus 로고    scopus 로고
    • Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus
    • 19307526 10.1001/archinternmed.2009.20 1:CAS:528:DC%2BD1MXksVOntrY%3D
    • Kooy A, de Jager J, Lehert P et al (2009) Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus. Arch Intern Med 169:616-625
    • (2009) Arch Intern Med , vol.169 , pp. 616-625
    • Kooy, A.1    De Jager, J.2    Lehert, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.